Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-16

FDA Approved: DIFLUNISAL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental abbreviated new drug application for DIFLUNISAL (diflunisal) from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc., unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIFLUNISAL (Diflunisal)

Snippet

SUPPL AP for DIFLUNISAL (DIFLUNISAL)